ES71
TEAS SECTION 71 RECEIVED
06/30/2026
Back to search
Official data from USPTO
PHARA PHARMACEUTICAL REGULATORY AFFAIRS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/01/2026
Trademark type
Combined
Nice classes
35
Filing date
12/21/2018
Registration date
06/30/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2020
Last transaction
07/01/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
68
Owner location
BE
Examiner
BIACHE, AUBREY
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "PHARA" in red above the stylized wording "PHARMACEUTICAL REGULATORY AFFAIRS" in red.
Holders and representatives
Holders
PhaRA Holding, besloten vennootschap metbeperkte aansprakelijkheid
Representatives
Andrew T. Rissler Patel IP, P.C.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business administrative consultancy with regard to the submission of New Drug Applications (NDAs) to the United States Food and Drug Administration (FDA) and Marketing Authorisation Applications (MMAs) to the EMA; business administrative services for the registration of physiciansinvestigations and research methods in the field of medicineupdating and maintenance of information in registries; interim business management; personnel placement and recruitment; Employment recruiting servicesassistance relating to recruitment and placement of staff; consultancy with regard to personnel recruitment; personnel selection using psychological testing; psychological testing for the selection of personnel for the purposes of assessing professional expertise; Employment recruiting consultationassessment of personnel requirements; provision of commercial and business contact informationcommercial mediation in establishing business contacts between applicants and providers of medical services; lobbying for commercial purposes related to the medical and the pharmaceutical sectors by consulting with care providers in order to be able to provide the necessary customized care; organisation of events for advertising and/or commercial purposes; compilation of data files into computer databases and database management of data files; mediation and conclusion of commercial transactions for othersmediation in the establishment of business contactsincluding in the context of medical and pharmaceutical services; the aforesaid services also provided via telecommunications channelsincluding the internet; commercial-business advice for the business management of a hospital and/or clinic; consultancy regarding business organisation and business economics; business administration services; business administrative servicesproviding office functions; business management; business organizationbusiness economics being business information and business assistance services during commercialization and business management of a clinicmedical center being a franchise; psychological testing for the selection of personnel; professional business consultancy
Publications
History of USPTO decisions and trademark events.
30 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/30/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/22/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
10/22/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/30/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/14/2020
PUBO
PUBLISHED FOR OPPOSITION
04/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/10/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/10/2020
GNFR
FINAL REFUSAL E-MAILED
03/10/2020
CNFR
FINAL REFUSAL WRITTEN
03/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/11/2020
RFNT
REFUSAL PROCESSED BY IB
09/20/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/05/2019
RFRR
REFUSAL PROCESSED BY MPU
09/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/21/2019
CNRT
NON-FINAL ACTION WRITTEN
08/20/2019
MAFR
APPLICATION FILING RECEIPT MAILED
08/06/2019
DOCK
ASSIGNED TO EXAMINER
07/31/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/31/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/27/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/18/2019
Continuous trademark protection
Get notified about every new filing that threatens PHARA PHARMACEUTICAL REGULATORY AFFAIRS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.